Clinical Trials List
Protocol NumberCA209-796
Not yet recruiting
2018-09-27 - 2020-12-31
Phase II
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳俊男 Division of Otolaryngology
- 陳贈成 Division of Otolaryngology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- RUEY-LONG HONG Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
41 participants
